FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: In a mouse model of fukutin-deficient dystroglycanopathy, all antibodies detected low molecular weight alpha-dystroglycan in disease samples demonstrating a loss of functional glycosylation.